Product Categories
Country: | United States |
---|---|
Tel: | +1-781-999-5354 |
Mobile: | +1-00000000000 |
E-mail: | marketing@targetmol.com |
QQ: | |
Skype: | Chat Now! |
Address: | 36?Washington?Street, Wellesley?Hills |
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
Product Name | MF | CAS | Details |
---|
INCB054329;INCB-054329,INCB-54329 | C19H16N4O3 | 1628607-64-6 | Details |
ER 27319 maleate | C22H24N2O5 | 1204480-26-1 | Details |
SYM 2081 | C6H11NO4 | 31137-74-3 | Details |
Methylprednisolone Aceponate | C27H36O7 | 86401-95-8 | Details |
Metyrosine;α-Methyltyrosine | C10H13NO3 | 672-87-7 | Details |
Nicardipine | C26H29N3O6 | 55985-32-5 | Details |
Ranatensin | C61H84N16O13S | 29451-71-6 | Details |
Parsaclisib hydrochloride;Parsaclisib HCl;INCB 050465;INCB-050465;INCB-50465;INCB050465 HCl;INCB50465 HCl;INCB 50465 | C20H23Cl2FN6O2 | 1995889-48-9 | Details |
GSK730 | C16H16F3N3O2 | 1260243-45-5 | Details |
(S)-AMG-510 | C30H30F2N6O3 | 2252403-56-6 | Details |
ETP-45658 | C16H17N5O2 | 1198357-79-7 | Details |
Terlipressin Acetate | C54H78N16O17S2 | 1884420-36-3 | Details |
Ro 04-5595 hydrochloride | C19H23Cl2NO2 | 64047-73-0 | Details |
Valemetostat | C26H34ClN3O4 | 1809336-39-7 | Details |
L-741,742 hydrochloride | C23H26Cl2N2O | 874882-93-6 | Details |
CPI098;CPI 098;CPI-098 | C10H12N2O | 3967-01-9 | Details |
NBI-27914 hydrochloride | C18H20Cl4N4.ClH | 1215766-76-9 | Details |
SB 206553 hydrochloride | C17H17ClN4O | 1197334-04-5 | Details |
IMB-808;IMB808;IMB 808 | C18H15F3N2O4 | 870768-70-0 | Details |
PAOPA | C11H18N4O3 | 114200-31-6 | Details |
Virodhamine trifluoroacetate;Virodhamine trifluoroacetate salt;Virodhamine-trifluoroacetate | C24H38F3NO4 | 1415264-56-0 | Details |
CYM-5478 | C21H19F3N2O2 | 870762-83-7 | Details |
Tyrphostin B44, (+) enantiomer | C18H16N2O3 | 133550-37-5 | Details |
Takeda103A | C24H23F2N7O | 865609-72-9 | Details |
Dihydrotachysterol;HSDB-3314;HSDB 3314;Parterol;Hytakerol;HSDB3314 | C28H46O | 67-96-9 | Details |
Tropinone | C8H13NO | 532-24-1 | Details |
SC-10 | C17H22ClNO2S | 102649-79-6 | Details |
Dodecenylsuccinic anhydride;Rikacid DDSA;DDSA;Dodecenylsuccinic acid anhydride | C16H26O3 | 25377-73-5 | Details |
Flunixin;Flunixinum;Flunixino;Flunixine;Sch-14714;Sch 14714;Sch14714 | C14H11F3N2O2 | 38677-85-9 | Details |
ND-2158;ND 2158;ND2158 | C22H30N4O4S | 1388896-07-8 | Details |
SSR180711 hydrochloride | C14H17BrN2O2.ClH | 446031-79-4 | Details |
Sulbactam pivoxil;CP47,904;CP47904;CP 47904;CP-47,904;CP 47,904;CP-47904 | C14H21NO7S | 69388-79-0 | Details |
1,1'-Biphenyl, 2-iodo-;NSC9283;NSC-9283;NSC 9283 | C12H9I | 2113-51-1 | Details |
RBI-257 Maleate | C25H32IN3O5 | 911378-38-6 | Details |
Trometamol hydrochloride | C4H12ClNO3 | 1185-53-1 | Details |
Nitrosoglutathione | C10H16N4O7S | 57564-91-7 | Details |
SS-208 | C13H11Cl2N3O4 | 2245942-72-5 | Details |
Crizotinib acetate;PF2341066;PF 02341066;PF-2341066;PF-02341066;PF02341066 | C23H26Cl2FN5O3 | 877399-53-6 | Details |
Boc5;Boc 5;Boc-5 | C54H52N4O16S2 | 917569-14-3 | Details |
Niclofolan;Niclofolano;Bilevon M;Menichlopholan;Niclofolanum;ME-3625 | C12H6Cl2N2O6 | 10331-57-4 | Details |
Bensulfuron-methyl;F 5384;DPX 84;F-5384;F5384 | C16H18N4O7S | 83055-99-6 | Details |
Lometraline hydrochloride;CP-14,368-1;Lometraline HCl;UNII-T2OJ193WGR;CP 14,368-1 | 34552-78-8 | Details |
Remoxipride | C16H23BrN2O3 | 80125-14-0 | Details |
Hydrocortisone Valerate | C26H38O6 | 57524-89-7 | Details |
FR-182024;FR 182024;FR182024 | C18H16N4O4S3 | 179034-83-4 | Details |
Lilial | C14H20O | 80-54-6 | Details |
Bifeprunox Mesylate | C25H27N3O5S | 350992-13-1 | Details |
HA-1004 | C12H15N5O2S | 91742-10-8 | Details |
SB-235699;SB 235699;HEP 689;SB235699;HEP689;HEP-689 | C19H19FN4 | 180869-32-3 | Details |
Tenuazonic acid | C10H15NO3 | 610-88-8 | Details |
Demethoxyrapamycin;AY-24668;AY24668;AY 24668 | C50H77NO12 | 83482-58-0 | Details |
Alclometasone dipropionate | C28H37ClO7 | 66734-13-2 | Details |
Levallorphan tartrate;Lorfan | C19H25NO.C4H6O6 | 71-82-9 | Details |
Hydroxyzine | C21H27ClN2O2 | 68-88-2 | Details |
L-Carnitine hydrochloride;Levocarnitine chloride;LC 80;(R)-Carnitine hydrochloride;LC-80;LC80;L-Carnitine chloride | C7H16ClNO3 | 6645-46-1 | Details |
Butralin | C14H21N3O4 | 33629-47-9 | Details |
11-deoxy-PGF2a | C20H34O4 | 37786-06-4 | Details |
PF-04781340;PF 04781340;PF04781340 | C17H21N3 | 1648726-56-0 | Details |
Vif-A3G Inhibitor N.41;VifA3G Inhibitor N.41;Vif-A3G Inhibitor-N.41 | C15H14N2O2 | 357441-99-7 | Details |
3-Hydroxybiphenyl | C12H10O | 580-51-8 | Details |
DIDS | C16H10N2O6S4 | 53005-05-3 | Details |
Ametryn;Cemerin;Gesapax;Doruplant;Topazol;Crisatrine;Gardopax | C9H17N5S | 834-12-8 | Details |
AZD-3199 free base;AZD 3199;AZD-3199;AZD3199 | C32H42N4O4S | 925243-19-2 | Details |
Methyl 2,6-dichlorobenzoate;2,6-Dichlorobenzoic acid methyl ester | C8H6Cl2O2 | 14920-87-7 | Details |
NS 3763 | C22H16N2O6 | 70553-45-6 | Details |
Pamaqueside;L-165313;CP 148623;L 165313;L165313;CP-148,623 | C39H62O14 | 150332-35-7 | Details |
AC-178335;AC178335;AC 178335 | C49H63N13O7 | 212966-15-9 | Details |
DRF 2519;DRF2519;DRF-2519 | C20H18N2O5S | 194713-46-7 | Details |
LAPAO;Lauramidopropylamine oxide | C17H36N2O2 | 61792-31-2 | Details |
Hetrombopag olamine | C27H29N5O6 | 1257792-42-9 | Details |
A 204;Antibiotic A-204;A-204;A204;Antibiotic A204;Antibiotic A 204 | 12750-79-7 | Details |
5-Methylurapidil;5-Methyl-urapidil;5Methylurapidil;5 Methylurapidil | C21H31N5O3 | 34661-85-3 | Details |
Pifithrin-β | C16H16N2S | 60477-34-1 | Details |
SKF1 | C23H37ClN2O2 | 678997-25-6 | Details |
Annaosanchun | C19H32O3 | 4725-51-3 | Details |
TAS4464 | C21H23FN6O6S | 1848959-10-3 | Details |
NSC-79887 | C14H16ClNO4 | 19056-78-1 | Details |
BU 224 hydrochloride | C12H12ClN3 | 205437-64-5 | Details |
PPNDS | C18H11N4Na4O14PS2 | 1021868-77-8 | Details |
DMH2;DMH 2;DMH-2 | C27H25N5O2 | 1206711-14-9 | Details |
Trk-IN-4;PF-6683324 isomer | C24H23F4N5O4 | 1799788-94-5 | Details |
AZD7268;AZD-7268;AZD 7268 | C29H30N4O2S | 1018988-00-5 | Details |
CATPB | C19H17ClF3NO3 | 1322598-09-3 | Details |
Entacapone acid | C10H6N2O6 | 160391-70-8 | Details |
Phenanthriplatin;cis-[Pt(NH3)2-(phenanthridine)Cl]NO3 | C13H13ClN4O3Pt | 1416900-51-0 | Details |
GSK854 | C18H19ClN6O4S2 | 1316059-00-3 | Details |
PD 81723 | C14H12F3NOS | 132861-87-1 | Details |
Cedazuridine | C9H14F2N2O5 | 1141397-80-9 | Details |
SPL-707 | C27H28FN5O4 | 2195361-33-0 | Details |
Norbormide;Raticate;MCN 1025;Mcneil 1025;S 6999;Shoxin | C33H25N3O3 | 991-42-4 | Details |
SB 204070 hydrochloride;SB 204070 HCl | C19H27ClN2O4 | 148702-58-3 | Details |
Kendomycin | C29H42O6 | 183202-73-5 | Details |
Bromotetrandrine;W198;5-Bromotetrandrine;W-198;BrTet;W 198 | C38H41BrN2O6 | 62067-29-2 | Details |
BMT-052;BMT 052;BMT052 | C30H26F4N6O5 | 1628720-84-2 | Details |
Cortistatin A;Cortistatin-A | C30H36N2O3 | 882976-95-6 | Details |
PNU-282987 S enantiomer hydrochloride;(S)-PNU-282987 HCl | C14H18Cl2N2O | 128311-08-0 | Details |
Org-34517;SCH-900636;SCH 900636;Org34517;SCH900636;Org 34517 | C28H30O4 | 189035-07-2 | Details |
MIN-117;Wf516;Wf 516;MIN 117;Wf-516;MIN117 | C25H26Cl3N3O4 | 310392-93-9 | Details |
PDI-IN-P1;PDIINP1;PDI inhibitor P1;PDI-inhibitor-P1;PDI IN P1 | C30H37N3O7S | 1461648-55-4 | Details |
COR 170 | C31H36N2O2 | 1048039-15-1 | Details |
Product Total: Product Page: | ||||
167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 |